Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlle... by Foley, John F, Defer, Gilles, Ryerson, Lana Zhovtis, Cohen, Jeffrey A, Arnold, Douglas L, Butzkueven, Helmut, Cutter, Gary, Giovannoni, Gavin, Killestein, Joep, Wiendl, Heinz, Smirnakis, Karen, Xiao, Shan, Kong, George, Kuhelj, Robert, Campbell, Nolan, van der Walt, Anneke, Dwyer, Christopher, Buzzard, Katherine, Spies, Judith, Parratt, John, van Pesch, Vincent, Willekens, Barbara, Perrotta, Gaetano, Bartholomé, Emmanuel, Grand'Maison, Francois, Jacques, Francois, Giacomini, Paul, Vosoughi, Reza, Girard, Jean-Marc, de Seze, Jerome, Lebrun Frenay, Christine, Ruet, Aurelie, Laplaud, David-Axel, Reifschneider, Gerd, Wagner, Bert, Rauer, Sebastian, Pul, Refik, Seipelt, Maria, Berthele, Achim, Klotz, Luisa, Kallmann, Boris-Alexander, Paul, Friedemann, Achiron, Anat, Lus, Giacomo, Centonze, Diego, Patti, Francesco, Grimaldi, Luigi, Hupperts, Raymond, Frequin, Stephan, Fermont, Jiske, Madueno, Sara Eichau, Alonso Torres, Ana Maria, Costa-Frossard França, Lucienne, Meca-Lallana, Jose Eustasio, Ruiz, Luis Brieva, Pearson, Owen, Rog, David, Evangelou, Nikolaos, Ismail, Azza, Lathi, Ellen, Fox, Edward, Leist, Thomas, Sloane, Jacob, Wu, Gregory, Khatri, Bhupendra, Steingo, Brian, Thrower, Ben, Gudesblatt, Mark, Calkwood, Jonathan, Bandari, Daniel, Scagnelli, John, Laganke, Christopher, Robertson, Derrick, Kipp, Lucas, Belkin, Martin, Cohan, Stanley, Goldstick, Lawrence, Courtney, Ardith, Vargas, Wendy, Sylvester, Andrew, Srinivasan, Jayshri, Kannan, Meena, Picone, Maryann, English, Jeffrey, Napoli, Salvatore, Balabanov, Roumen, Zaydan, Islam, Nicholas, Jacqueline, Kaplan, Jeffrey, Lublin, Fred, Riser, Emily, Miller, Tamara, Alvarez, Enrique, Wray, Sibyl, Gross, Jeffrey, Pawate, Siddharama, Hersh, Carrie, McCarthy, Lucas, Crayton, Heidi, Graves, Jennifer

Get full text

Topical VEGF enhances healing of thoracic aortic anastomosis for coarctation in a rabbit model by SEIPELT, Ralf G, BACKER, Carl L, MAVROUDIS, Constantine, STELLMACH, Veronica, SEIPELT, Ingrid M, CORNWELL, Mona, HERNANDEZ, Jose, CRAWFORD, Susan E

Get full text

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity by Ostkamp, Patrick, Salmen, Anke, Pignolet, Béatrice, Görlich, Dennis, Andlauer, Till F. M., Schulte-Mecklenbeck, Andreas, Gonzalez-Escamilla, Gabriel, Bucciarelli, Florence, Gennero, Isabelle, Breuer, Johanna, Antony, Gisela, Schneider-Hohendorf, Tilman, Mykicki, Nadine, Bayas, Antonios, Bergh, Florian Then, Bittner, Stefan, Hartung, Hans-Peter, Friese, Manuel A., Linker, Ralf A., Luessi, Felix, Lehmann-Horn, Klaus, Mühlau, Mark, Paul, Friedemann, Stangel, Martin, Tackenberg, Björn, Tumani, Hayrettin, Warnke, Clemens, Weber, Frank, Wildemann, Brigitte, Zettl, Uwe K., Ziemann, Ulf, Müller-Myhsok, Bertram, Kümpfel, Tania, Klotz, Luisa, Meuth, Sven G., Zipp, Frauke, Hemmer, Bernhard, Hohlfeld, Reinhard, Brassat, David, Gold, Ralf, Gross, Catharina C., Lukas, Carsten, Groppa, Sergiu, Loser, Karin, Wiendl, Heinz, Schwab, Nicholas

Get full text

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack... by Kümpfel, Tania, Giglhuber, Katrin, Aktas, Orhan, Ayzenberg, Ilya, Bellmann-Strobl, Judith, Häußler, Vivien, Havla, Joachim, Hellwig, Kerstin, Hümmert, Martin W., Jarius, Sven, Kleiter, Ingo, Klotz, Luisa, Krumbholz, Markus, Paul, Friedemann, Ringelstein, Marius, Ruprecht, Klemens, Senel, Makbule, Stellmann, Jan-Patrick, Bergh, Florian Then, Trebst, Corinna, Tumani, Hayrettin, Warnke, Clemens, Wildemann, Brigitte, Berthele, Achim

Get full text

98 AEZS-129, an orally active PI3K inhibitor in preclinical development by Seipelt, I, Guenther, E, Baasner, S, Blumenstein, L, Mueller, G, Fensterle, J, Engel, J, Teifel, M, Gerlach, M

Get full text

197 AEZS-132, a new orally bioavailable PI3K/Erk inhibitor with antitumor effects by Seipelt, I, Gerlach, M, Baasner, S, Blumenstein, L, Mueller, G, Aicher, B, Engel, J, Guenther, E, Teifel, M

Get full text

Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). P... by Kümpfel, Tania, Giglhuber, Katrin, Aktas, Orhan, Ayzenberg, Ilya, Bellmann-Strobl, Judith, Häußler, Vivien, Havla, Joachim, Hellwig, Kerstin, Hümmert, Martin W., Jarius, Sven, Kleiter, Ingo, Klotz, Luisa, Krumbholz, Markus, Paul, Friedemann, Ringelstein, Marius, Ruprecht, Klemens, Senel, Makbule, Stellmann, Jan-Patrick, Bergh, Florian Then, Trebst, Corinna, Tumani, Hayrettin, Warnke, Clemens, Wildemann, Brigitte, Berthele, Achim

Get full text

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study by Mohty, Mohamad, Lejniece, Sandra, Beksac, Meral, Bekadja, Mohamed Amine, Stankovic, Svetlana, De Stefano, Valerio, Kochkareva, Yulia, Laane, Edward, Salwender, Hans, Masliak, Zvenyslava, Silva, João, Louw, Vernon, Abadi, Uri, Couturier, Catherine, Feys, Caroline, Thoret-Bauchet, Florence, Bekadja, Mohamed, Ali, Hocine Ait, Hamdi, Selma, Touhami, Hadj, Pedersen, Robert Shou, Laane, Edward, Hein, Marju, Moreau, Philippe, Cartron, Guillaume, Dine, Gérard, Harich, Hanns-Detlev, Illmer, Thomas, Dörfel, Steffen, Koenigsmann, Michael, Schlag, Rudolf, Uhlig, Jens, Schütz, Stefan, Tessen, Hans-Werner, Mohr, Benno, Heinrich, Bernhard, Von Weikersthal, Ludwig Fischer, Heßling, Jörg, Schauer, Michael, Dürk, Heinz, Hess, Georg, Matsouka, Panagiota, Ivanyi, Janos, Abadi, Uri, Avivi, Irit, Foa, Roberto, Corso, Alessandro, Ferrara, Felicetto, Cantonetti, Maria, Di Raimondo, Francesco, Pizzuti, Michele, Farina, Gabriella, La Nasa, Giorgio, Cangialosi, Clotilde, Federici, Augusto, Romano, Atelda, Specchia, Giorgina, Latte, Giancarlo, Mannina, Donato, Pečeliūnas, Valdas, Jurgutis, Mindaugas, Stankovic, Svetlana, Homenda, Wojciech, Starzak-Gwozdz, Jolanta, Komarnicki, Mieczyslaw, Gonçalves, Cristina, Esefyeva, Natalia, Kochkareva, Julia, Kaplanov, Kamil, Laricheva, Elena, Dergacheva, Valentina, Nazarova, Irina, Anchukova, Ludmila, Ovanesova, Elena, Gritsenko, Taras, Kuznetsova, Irina, Osyunikhina, Svetlana, Serdyuk, Olga, Karyagina, Elena, Ivanova, Valentina, Gutiérrez, Asunción Echeveste, Capote, Francisco Javier, Sanchez, Jesus Martin, Ibañez-Garcia, Jeronima, Herranz, Maria Jose, Sanchez, Sara Sanchez, Lleonart, Joan Bargay, Martínez, Rafael, De La Serna, Javier, Mateos, Maria-Victoria, Beksac, Turkey – Meral, Aydin, Yildiz, Bilgir, Oktay, Ali, Ridvan, Kyselyova, Maryna, Dyagil, Iryna, Yushchenko, Natalia, Kozlov, Viktor, Harousseau, Jean-Luc, De la Rubia, Javier

Get full text

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry by Simbrich, Alexandra, Thibaut, Jasmine, Khil, Laura, Maximov, Stanislav, Wiendl, Heinz, Berger, Klaus

Get full text

Fulminant Toxoplasmosis in a Heart Transplant Recipient by Hermanns, Benita, Brunn, Anne, Schwarz, Ernst R., Sachweh, Jörg S., Seipelt, Ingrid, Schröder, J. Michael, Vogel, Ulrich, Schoendube, Friedrich A., Buettner, Reinhard

Get full text

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a... by Rahbari, Nuh N, Lordick, Florian, Fink, Christine, Bork, Ulrich, Stange, Annika, Jäger, Dirk, Luntz, Steffen P, Englert, Stefan, Rossion, Inga, Koch, Moritz, Büchler, Markus W, Kieser, Meinhard, Weitz, Jürgen

Get full text

P3-18-06: AEZS-131 – A Highly Selective ERK-Inhibitor: Characterization and Preclinical Testing in Triple Negative Breast Cancer (TNBC) by Engel, JB, Seipelt, I, Hönig, A, Hahne, JC, Teifel, M

Get full text

Overexpression, purification, and use of a soluble human interleukin-4 receptor alpha-chain/Ig gamma 1 fusion protein for ligand binding studies. Characterization of ligand binding... by Seipelt, I, Hoffmann, S H, Schmidt, J, Engels, J W, Beckers, T

Get full text

AEZS-131– ein hochselektiver ERK-Inhibitor: Charakterisierung und präklinische Testung im tripelnegativen Mammakarzinom (TNBC) by Engel, JB, Seipelt, I, Hönig, A, Hahne, JC, Teifel, M

Get full text

Intracellular Cryptococcus neoformans disrupts the transcriptome profile of M1- and M2-polarized host macrophages by Subramani, Aarthi, Griggs, Prianca, Frantzen, Niah, Mendez, James, Tucker, Jamila, Murriel, Jada, Sircy, Linda M, Millican, Grace E, McClelland, Erin E, Seipelt-Thiemann, Rebecca L, Nelson, David E

Get full text

Prenatal maternal vitamin D deficiency sex‐dependently programs adipose tissue metabolism and energy homeostasis in offspring by Seipelt, Eva M., Tourniaire, Franck, Couturier, Charlène, Astier, Julien, Loriod, Béatrice, Vachon, Hortense, Pucéat, Michel, Mounien, Lourdes, Landrier, Jean‐François

Get full text

Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study by Stintzing, S, Miller-Phillips, L, Modest, D.P, Fischer von Weikersthal, L, Decker, T, Kiani, A, Vehling-Kaiser, U, Al-Batran, S.-E, Heintges, T, Kahl, C, Seipelt, G, Kullmann, F, Stauch, M, Scheithauer, W, Held, S, Moehler, M, Jagenburg, A, Kirchner, T, Jung, A, Heinemann, V

Get full text

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial by Heinemann, Volker, Prof, von Weikersthal, Ludwig Fischer, MD, Decker, Thomas, MD, Kiani, Alexander, Prof, Vehling-Kaiser, Ursula, MD, Al-Batran, Salah-Eddin, Prof, Heintges, Tobias, Prof, Lerchenmüller, Christian, MD, Kahl, Christoph, MD, Seipelt, Gernot, MD, Kullmann, Frank, Prof, Stauch, Martina, MD, Scheithauer, Werner, Prof, Hielscher, Jörg, Scholz, Michael, MD, Müller, Sebastian, MD, Link, Hartmut, Prof, Niederle, Norbert, Prof, Rost, Andreas, MD, Höffkes, Heinz-Gert, Prof, Moehler, Markus, Prof, Lindig, Reinhard U, MD, Modest, Dominik P, MD, Rossius, Lisa, MD, Kirchner, Thomas, Prof, Jung, Andreas, PhD, Stintzing, Sebastian, MD

Get full text

FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial by Heinemann, Volker, von Weikersthal, Ludwig Fischer, Decker, Thomas, Kiani, Alexander, Kaiser, Florian, Al-Batran, Salah-Edin, Heintges, Tobias, Lerchenmüller, Christoph, Kahl, Christoph, Seipelt, Gernot, Kullmann, Frank, Moehler, Markus, Scheithauer, Werner, Held, Swantje, Miller-Phillips, Lisa, Modest, Dominik Paul, Jung, Andreas, Kirchner, Thomas, Stintzing, Sebastian

Get full text

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this... by Stintzing, Sebastian, Dr, Modest, Dominik P, MD, Rossius, Lisa, Lerch, Markus M, Prof, von Weikersthal, Ludwig Fischer, MD, Decker, Thomas, MD, Kiani, Alexander, MD, Vehling-Kaiser, Ursula, MD, Al-Batran, Salah-Eddin, Prof, Heintges, Tobias, MD, Lerchenmüller, Christian, MD, Kahl, Christoph, MD, Seipelt, Gernot, MD, Kullmann, Frank, MD, Stauch, Martina, MD, Scheithauer, Werner, Prof, Held, Swantje, MSc, Giessen-Jung, Clemens, MD, Moehler, Markus, Prof, Jagenburg, Andreas, MD, Kirchner, Thomas, Prof, Jung, Andreas, Prof, Heinemann, Volker, Prof

Get full text